CAPR R&D Expenses
Capricor Therapeutics Inc · R&D Expenses
CAPR R&D Expenses
Latest reported$99.73Mperiod ending
CAPR TTM R&D Expenses ($0.00 → $99.73M)
TTM R&D Expenses
High-resolution chart · PNG
CAPR r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 99,734,973 | |
| 92,915,935 | |
| 84,454,595 | |
| 75,876,860 | |
| 67,325,629 | |
| 57,783,144 | |
| 49,968,585 | |
| 45,353,816 | |
| 43,574,913 | |
| 39,887,533 | |
| 36,448,039 | |
| 32,739,678 | |
| 28,215,070 | |
| 24,362,769 | |
| 21,816,949 | |
| 19,848,676 | |
| 16,858,235 | |
| 15,390,422 | |
| 13,571,045 | |
| 12,052,616 | |
| 12,167,968 | |
| 10,598,166 | |
| 8,457,000 | |
| 6,540,645 | |
| 4,769,142 | |
| 4,485,669 | |
| 5,141,513 | |
| 7,161,764 | |
| 9,436,000 | |
| 11,181,000 | |
| 12,067,000 | |
| 11,736,000 | |
| 10,466,000 | |
| 10,205,000 | |
| 10,765,000 | |
| 10,913,000 | |
| 13,778,000 | |
| 14,958,000 | |
| 16,042,000 | |
| 16,707,000 | |
| 15,173,000 | |
| 14,292,000 | |
| 13,758,000 | |
| 13,011,000 | |
| 11,785,000 | |
| 10,214,000 | |
| 7,782,000 | |
| 10,265,000 | |
| 9,309,000 | |
| 8,765,000 | |
| 8,581,000 | |
| 3,560,984 | |
| 2,729,126 | |
| 1,749,576 | |
| 1,023,929 | |
| 2,318,945 | |
| 3,609,803 | |
| 3,980,283 | |
| 4,137,262 | |
| 3,358,324 | |
| 3,037,324 | |
| 3,390,394 | |
| 4,081,062 | |
| 4,407,272 | |
| 4,407,272 | |
| 4,454,272 | |
| 4,466,272 | |
| 5,631,000 | |
| 7,039,000 | |
| 8,825,000 | |
| 9,478,000 | |
| 8,951,000 | |
| 8,570,000 | |
| 6,544,029 | |
| 5,124,277 | |
| 3,597,277 | |
| 2,196,049 | |
| 1,333,020 | |
| 774,772 | |
| 774,772 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |